Clinical Trials in Baltimore

Showing 461-480 of 23,476 trials

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

NCT06738407

The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.

GonorrheaChlamydiaSyphilis+1 more

Westat760 participantsStarted Feb 2026

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +10 more locations

Active Not RecruitingPhase 1< 1 mile

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

NCT04526691

This study will assess safety and treatment activity of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab with or without platinum chemotherapy in participants with advanced or metastatic non-small cell lung cancer.

Advanced or Metastatic NSCLC

Daiichi Sankyo145 participantsStarted Sep 2020

Scottsdale, Arizona, United States • Duarte, California, United States • Washington D.C., District of Columbia, United States +21 more locations

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

Find Trials by Condition in Baltimore

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

Bilevel Positive Airway Pressure (BPAP) for Severe Asthma

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Dissemination and Implementation of the Bright Bodies Intervention for Childhood Obesity

St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)